528 filings
Page 9 of 27
10-Q
2021 Q1
CTXR
Citius Pharmaceuticals Inc
Quarterly report
11 Feb 21
4:05pm
SEC STAFF
CTXR
Citius Pharmaceuticals Inc
11 Feb 21
SEC staff action: Order
12:00am
8-K
CTXR
Citius Pharmaceuticals Inc
9 Feb 21
Submission of Matters to a Vote of Security Holders
4:04pm
EFFECT
CTXR
Citius Pharmaceuticals Inc
8 Feb 21
Notice of effectiveness
12:15am
424B3
CTXR
Citius Pharmaceuticals Inc
5 Feb 21
Prospectus supplement
5:15pm
UPLOAD
CTXR
Citius Pharmaceuticals Inc
3 Feb 21
Letter from SEC
12:00am
CORRESP
CTXR
Citius Pharmaceuticals Inc
3 Feb 21
Correspondence with SEC
12:00am
D
CTXR
Citius Pharmaceuticals Inc
1 Feb 21
$20M in equity / options, sold $20M, 7 investors
12:43pm
S-3
CTXR
Citius Pharmaceuticals Inc
Shelf registration
29 Jan 21
4:06pm
8-K
CTXR
Citius Pharmaceuticals Inc
27 Jan 21
Citius Pharmaceuticals Announces $20.0 Million
4:15pm
8-K
CTXR
Citius Pharmaceuticals Inc
11 Jan 21
Other Events
8:16am
DEFA14A
CTXR
Citius Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
4:06pm
DEF 14A
CTXR
Citius Pharmaceuticals Inc
Definitive proxy
21 Dec 20
4:05pm
10-K
2020 FY
CTXR
Citius Pharmaceuticals Inc
Annual report
16 Dec 20
4:05pm
8-K
CTXR
Citius Pharmaceuticals Inc
9 Dec 20
Citius Pharmaceuticals Receives FDA Response and Guidance to Pre-IND Consultation Submission for Mino-Wrap
4:15pm
8-K
CTXR
Citius Pharmaceuticals Inc
8 Dec 20
Other Events
9:25am
8-K
CTXR
Citius Pharmaceuticals Inc
30 Nov 20
Citius Announces Results of Study that Mino-Lok Eradicates S. aureus Biofilm More Effectively and Expeditiously than Components
9:23am
8-K
CTXR
Citius Pharmaceuticals Inc
26 Oct 20
Other Events
8:30am
8-K
CTXR
Citius Pharmaceuticals Inc
9 Oct 20
Entry into a Material Definitive Agreement
4:14pm
4
Kane William
9 Oct 20
Citius Pharmaceuticals / William Kane ownership change
4:09pm